Glenmede Trust’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-12,575
| Closed | -$469K | – | 1361 |
|
|
2021
Q2 | $469K | Sell |
12,575
-938
| -7% | -$35K | ﹤0.01% | 911 |
|
|
2021
Q1 | $345K | Buy |
13,513
+223
| +2% | +$5.69K | ﹤0.01% | 946 |
|
|
2020
Q4 | $291K | Buy |
13,290
+1,300
| +11% | +$28.5K | ﹤0.01% | 971 |
|
|
2020
Q3 | $215K | Buy |
11,990
+2,905
| +32% | +$52.1K | ﹤0.01% | 1009 |
|
|
2020
Q2 | $230K | Buy |
9,085
+2,230
| +33% | +$56.5K | ﹤0.01% | 973 |
|
|
2020
Q1 | $151K | Hold |
6,855
| – | – | ﹤0.01% | 1291 |
|
|
2019
Q4 | $151K | Buy |
+6,855
| New | +$151K | ﹤0.01% | 1291 |
|